| ID | Name | CAS | Properties |
logPoct/wat |
| 44-173-1 |
3«alpha»,16«alpha»,17«beta»-Trihydroxy-5«beta»-androstane, tris-TMS
|
|
2 | 8.299 |
| 44-331-5 |
3-«beta»,7-«alpha»-Dihydroxy-4-cholenoic acid, methyl ester, TMS
|
|
2 | 8.205 |
| 44-369-4 |
2-Glucosyl-cellobiose: aD-Glcp(1->2)-bDGlcp(1->4)-DGlc, oxime-TMS, isomer # 2
|
|
2 | 14.359 |
| 44-462-0 |
2-(N-n-di-n-hexylamino)-3-(n-pentyl)-6-(n-heptyl) pyrazine
|
|
2 | 8.689 |
| 44-535-9 |
3A,11B,17A,20A,21-Pentahydroxy-5B-pregnane, tetrakis-TMS
|
|
2 | 8.882 |
| 44-595-3 |
Silane, [[(3«beta»,5«alpha»)-androstan-3-yl]oxy]trimethyl-
|
18899-44-0 |
2 | 6.639 |
| 44-638-5 |
d-Gluconic acid, 2,3,4,6-tetrakis-O-(trimethylsilyl)-, «delta»-lactone
|
32384-65-9 |
2 | 4.424 |
| 44-653-8 |
ent-6«alpha»,7«alpha»,16«beta»,17-Tetrahydroxy-16,17-dihydrokaurenoic acid, Me-TMS
|
|
2 | 8.233 |
| 44-797-9 |
Oxalacetic acid, enol-(tert-butyldimethylsilyl) ether, bis(tert-butyldimethylsilyl) ester
|
|
2 | 6.989 |
| 44-819-4 |
ent-16«beta»,17-H2(OH)2 7«alpha»-OH kaurenoic acid, MeTMSi
|
|
2 | 7.844 |
| 44-870-7 |
2,2,4,4-Tetramethyl-1,3-cyclobutane-1,3-diol, cis, bis-TMS
|
|
2 | 4.493 |
| 44-885-1 |
Silane, dimethyl(2,2,3,3,4,4,5,5-octafluoropentyloxy)isohexyloxy-
|
|
2 | 5.329 |
| 44-907-6 |
cis-Anthracene, 1,2,3,4-tetrahydro-1,2-diol, bis-TMS
|
|
2 | 5.899 |
| 45-040-7 |
O,O'-Bis(tert-butyldimethylsilyl) 2-amino-9-(2-hydroxyethoxymethyl)-purin-6-ol ether
|
|
2 | 4.788 |
| 45-193-8 |
Anthracene, 1,2,3,4-tetrahydro-cis-1,2-diol, DTBS
|
|
2 | 6.285 |
| 45-211-7 |
«alpha»-D-Glucopyranoside, 1,3,4,6-tetrakis-O-(trimethylsilyl)-«beta»-D-fructofuranosyl 2,3,4,6-tetrakis-O-(trimethylsilyl)-
|
19159-25-2 |
2 | 9.478 |
| 45-318-9 |
4-[2-(4-Allyl-2,6-dimethoxy-phenoxy)-1-hydroxy-propyl]-2-methoxy-phenol, TPS
|
|
2 | 11.180 |
| 45-336-9 |
5-«beta»-Pregnan-3-«alpha»,20-«alpha»-diol-11-one, MO-TMS
|
|
2 | 7.718 |
| 45-583-5 |
2,6-Dimethyl-5-[(diphenylmethyl)silyloxy]non-1-en-3-yne
|
|
2 | 4.777 |
| 45-693-3 |
5-«alpha»-Pregnane-3-«beta»,17-«alpha»,20-«alpha»-triol, methylboronate, TMS
|
|
2 | 6.541 |
| 45-713-0 |
3«alpha»,7«alpha»,12«alpha»,26-tetrahydroxy-5«beta»-C27-bile acid, methyl ester, TMS
|
|
2 | 10.973 |
| 45-776-1 |
4-METHYLHYDRAZONOMETHYL-2,2,5,5-TETRAMETHYL-3-IMIDAZOLINE-1-OXILE
|
|
2 | 0.808 |
| 45-844-5 |
4-Pregnen-3-«beta»,11-«beta»,20-«alpha»-triol, TMS
|
|
2 | 8.856 |
| 45-881-4 |
Androsta-1,4-dien-17«beta»-ol-3-one,bis-TMS
|
|
2 | 7.291 |
| 45-913-8 |
3-«alpha»-12-«alpha»-Dihydroxy-7-keto-5-«beta»-cholanoic acid, MeTMS
|
|
2 | 7.464 |
| 45-948-0 |
5-«beta»-Pregnan-20-«alpha»-ol-3,11-dione, MO-TMS
|
|
2 | 6.500 |
| 46-001-9 |
Methyl ([1,1,3,3,5,5-hexamethyl-5-(pyridin-3-ylmethoxy)trisiloxanyl]oxy)acetate
|
|
2 | 2.926 |
| 46-116-2 |
4H-1-Benzopyran-4-one, 2-[3,4-bis[(trimethylsilyl)oxy]phenyl]-3,5,7-tris[(trimethylsilyl)oxy]-
|
4067-66-7 |
2 | 9.529 |
| 46-174-8 |
5-Methyl-7-amino-s-triazolo(1,5-a)pyrimidine
|
33376-96-4 |
2 | 0.015 |
| 46-177-5 |
3-«alpha»,7-«beta»,22-Trihydroxy-5-«beta»-cholic acid, methyl ester, TMS
|
|
2 | 9.115 |
| 46-324-1 |
3-«beta»,15-«alpha»-Dihydroxy-5-androsten-17-one, MO TMS
|
|
2 | 7.002 |
| 46-408-8 |
7«alpha»,12«alpha»-dihydroxy-3-oxy-4-chol-24-oate, O-methyloxime (2)
|
|
2 | 9.022 |
| 46-584-3 |
9-Dodecyn-1-ol, dimethyl(pyrid-3-ylmethoxy)silyl ether
|
|
2 | 5.461 |
| 46-624-8 |
5«alpha»-Androstan-3«alpha»-ol-11,17-dione, TMS
|
|
2 | 8.550 |
| 46-705-8 |
Benzofuran-5-propanol, 2,3-dihydro-3-hydroxymethyl-7-methoxy-2-(4-hydroxy-3-methoxyphenyl), tris-TMS
|
|
2 | 7.770 |
| 46-735-5 |
17-«alpha»-Methyl-5-«alpha»-androstan-3-«beta»,17-«beta»-diol, per-TMS
|
|
2 | 7.859 |
| 46-740-9 |
3-«beta»,7-«alpha»,12-«alpha»-Trihydroxy-5-cholestenoic acid, methyl ester, TMS
|
|
2 | 10.061 |
| 46-796-8 |
3«alpha»,7«alpha»,12«alpha»,24(«epsilon»)-tetrahydroxy-5«beta»-cholestanoate, methyl ester-trimethylsilyl ether
|
|
2 | 10.971 |
| 46-873-2 |
ent-6«alpha»,7«alpha»,16«beta»,17-tetra-(OH)-16,17-dihydrokaurenonic acid, Me-TMS
|
|
2 | 8.674 |
| 47-192-7 |
15(S)-15-Methyl-PGA2, EO-TMS, isomer # 2
|
|
2 | 8.423 |
| 47-209-8 |
5-Pregnen-3-«beta»,20-«beta»-diol-11-one, MO-TMS
|
|
2 | 7.638 |
| 47-240-3 |
3«beta»,7«alpha»,12«alpha»-Trihydroxy-4-cholenic acid, methyl ester, TMS
|
|
2 | 9.035 |
| 47-278-2 |
2-[[tert-Butyl(dimethyl)silyl](methyl)amino]-1-(4-pyrrol[tert-butyl(dimethyl)silyl]oxymorpho-3-methoxyphenyl)ethanol
|
|
2 | 6.050 |
| 47-286-3 |
6-Chloro-2-methyl-7-methylsulfamyl-benzothiatriazine-1,1-dioxide
|
|
2 | 0.881 |
| 47-364-6 |
4-Imidazole carboxylic acid, 5[3-(beta-hydroxyethyl)-3-methyl-1-triazeno]-, methyl ester
|
36137-85-6 |
2 | -0.363 |
| 47-423-0 |
7-Amino-S-triazolo(1,5-a)pyrimidin-5(4H)-one
|
35186-69-7 |
2 | -1.482 |
| 47-457-3 |
Pentanedioic acid, 3-[(tert-butyldimethylsilyl)oxy]-3-methyl-, bis(tert-butyldimethylsilyl) ester
|
|
2 | 7.644 |
| 47-514-9 |
Phosphoric acid, bis(trimethylsilyl) 2,3-bis[(trimethylsilyl)oxy]propyl ester
|
31038-11-6 |
2 | 5.886 |
| 47-652-6 |
5«beta»-Cholestane-3«alpha»,7«alpha»,12«alpha»,25-tetrol, TMS
|
|
2 | 11.572 |
| 47-736-3 |
2«alpha»,3«alpha»-cyclopropane-5«alpha»-androstan-4.«alpha»,17«beta»-diol, bisTBDMS
|
|
2 | 9.666 |
| 47-792-1 |
d-Mannose, 2,3,4,5,6-pentakis-O-(trimethylsilyl)-, o-methyloxyme, (1Z)-
|
128705-67-9 |
2 | 6.351 |
| 47-877-7 |
3«alpha»,7«alpha»,12«alpha»-Trihydroxy-5«beta»-homocholanoic acid, MeTMS
|
|
2 | 9.505 |
| 47-938-9 |
Benzoic acid, 2-hydroxy-3-methyl-6-(1-methylethyl), DTBS
|
|
2 | 5.710 |
| 47-998-3 |
6«beta»-Hydroxy-17«alpha»-Methyltestosterone, tris-TMS (3,5-diene)
|
|
2 | 9.084 |
| 48-014-3 |
Idonic acid, 2,3,5,6-tetrakis-O-(trimethylsilyl)-, lactone
|
55515-32-7 |
2 | 4.424 |
| 48-017-0 |
N-(2-Hydroxy-propionyl)-4-methyl-benzenesulfonamide, O-tert.-butyldimethylsilyl-
|
|
2 | 3.210 |
| 48-279-0 |
4,6-Choladienoic acid, 12-«alpha»-hydroxy-3-one, methyl ester, TMS
|
|
2 | 6.330 |
| 48-487-9 |
5B-Androst-1-en-17B-methyl-3A,17A-diol, TMS
|
|
2 | 7.635 |
| 48-572-4 |
3«alpha»,5«beta»,12«alpha»-trihydroxy-5«beta»-cholan-24-oic acid, DMESI
|
|
2 | 12.024 |
| 48-594-0 |
Androst-1,4-dien-2z-hydroxymethyl-17«alpha»-methyl-11«alpha»,17«beta»-diol-3-one, TMS
|
|
2 | 10.299 |
| 48-687-7 |
3«alpha»,16«alpha»,17«beta»-Trihydroxy-5«alpha»-androstane, tris-TMS
|
|
2 | 8.299 |
| 48-760-5 |
16«alpha», 17-H2(OH)2 GA9 methyl ester TMS ether
|
|
2 | 4.165 |
| 48-830-7 |
4-Phenyl-4h-1,3,4-thiadiazine-2(3h)-thione
|
|
2 | 2.500 |
| 48-863-1 |
1,3-Disiloxane, 1,3-diethoxy, 1,3-dipropyl, 1,3-bis-(chloromethyl)
|
|
2 | 4.336 |
| 48-872-1 |
3«alpha»,6«beta»,7«beta»,12«beta»-Tetrahydroxy-5«beta»-cholanoic acid, methyl ester-trimethylsilyl ether
|
|
2 | 9.945 |
| 49-039-5 |
17-«beta»-Methyl-5-«beta»-androstan-3-«alpha»,17-«alpha»-diol, per-TMS
|
|
2 | 7.859 |
| 49-099-9 |
24-Nor-5B-Cholan-3A,7A,12A,23-tetrol, TMS
|
|
2 | 10.403 |
| 49-144-8 |
ent-6«alpha»,7«alpha»-Dihydroxy trachylobanic acid, Me-TMS
|
|
2 | 6.478 |
| 49-203-2 |
Formamide, n-(4-amino-6-chloro-5-pyrimidinyl)-n-cyclopentyl-
|
40067-41-2 |
2 | 1.618 |
| 49-350-9 |
1-(2-Methylbutoxy)-7-isohexyl-2,2,4,4,6,6-hexamethyl-1,3,5,7-tetraoxa-2,4,6-trisilaheptane
|
|
2 | 5.641 |
| 49-387-9 |
Urea, 1-methyl-1-nitroso-3-(1,2,3,4-tetrahydro-2,4-dioxo-5-pyrimidinyl)-
|
58494-42-1 |
2 | -1.756 |
| 49-421-0 |
D-(+)-Glucuronic acid «gamma»-lactone, tris(trimethylsilyl) ether, benzyloxime (isomer 1)
|
|
2 | 4.775 |
| 49-476-0 |
17-«alpha»-Methyl-5-«beta»-androstan-3-«alpha»,17-«beta»-diol, per-TMS
|
|
2 | 7.859 |
| 49-479-7 |
(2-Hydroxy-3-phenyl-1,2-dihydroquinoxalin-1-yl)phenyl(3-phenyl-1-benzyl-1,2-dihydroquinoxalin-2-yl)methane
|
91757-02-7 |
2 | 8.897 |
| 49-486-9 |
2,2,4,4-Tetramethylcyclobutane-1,3-diol, trans, bis-TMS ether
|
|
2 | 4.493 |
| 49-681-2 |
N6-acetyl-2'-Deoxyadenosine, 3'-O-TBDMS, 5'-O-acetyl
|
|
2 | 3.026 |
| 49-695-7 |
5«beta»-Pregnane-3«alpha», 11«beta», 21-triol-20-one (THB), MO TMS
|
|
2 | 8.549 |
| 49-700-0 |
Pyrido[2,3-b]pyrazine-6-carbamic acid, 8-[(diphenylmethyl)amino]-2,3-diphenyl-, ethyl ester
|
|
2 | 8.129 |
| 49-788-4 |
5-«beta»-Pregnan-11-«beta»-ol-20-one, MO-TMS
|
|
2 | 6.888 |
| 49-895-5 |
3«alpha»,7«alpha»,12«alpha»-trihydroxy-5«beta»-C27-bile acid, methyl ester, TMS
|
|
2 | 10.141 |
| 49-964-8 |
Dimethyl(bis{[5-methyl-2-(1-methylethenyl)hex-4-en-1-yl]oxy})silane
|
|
2 | 6.819 |
| 49-975-6 |
5«alpha»-Pregnan-3«beta»,20«alpha»-diol, allyl-DMS
|
|
2 | 8.828 |
| 50-024-9 |
Acetic acid, (3,4-dihydro-5-nitro-4-oxo-6-pyrimidinyl)hydrazide
|
30958-43-1 |
2 | -1.341 |
| 50-038-4 |
Triazolo [4,5-d]pyrimidine, 3h-v-, 5,7-diamino-3-ethyl-
|
7256-20-4 |
2 | -0.594 |
| 50-110-3 |
Urea, 1-(2-hydroxyethyl)-3-(1,2,3,4-tetrahydro-2,4-dioxo-5-pyrimidinyl)-
|
|
2 | -2.787 |
| 50-209-4 |
N-(3-Bromo-4-hydroxy-phenyl)-4-nitro-benzenesulfonamide, N,O-di(trimethylsilyl)-
|
|
2 | 5.601 |
| 50-214-8 |
Silane, (9,19-cyclo-9«beta»-lanost-24-en-3«beta»-yloxy)trimethyl-
|
17608-55-8 |
2 | 10.028 |
| 50-286-9 |
3-(4-Hydroxyphenyl)propionic acid, tert-butyldimethylsilyl ether, tert-butyldimethylsilyl ester
|
|
2 | 6.552 |
| 50-346-2 |
Oxadiazole, 1,2,4-, 5-(5-nitrofuran-2-yl)-3-(4-pyridinyl)-
|
|
2 | 2.300 |
| 50-387-7 |
Benzeneacetic acid, «alpha»,3,4-tris[(trimethylsilyl)oxy]-, trimethylsilyl ester
|
37148-65-5 |
2 | 6.385 |
| 50-415-5 |
17-«alpha»-Hydroxy-7-«alpha»,17-«alpha»-dimethyl-5-«beta»-androstan-3-one, per-TMS
|
|
2 | 8.231 |
| 50-503-7 |
Anthracene, 1,2,3,4-tetrahydro-trans-1,2-diol, DTBS
|
|
2 | 6.285 |
| 50-517-2 |
5«beta»-Homocholane-3«alpha»,7«alpha»,12«alpha»,25-tetrol, TMS
|
|
2 | 11.183 |
| 50-521-7 |
3«beta»,4«beta»,7«alpha»,12«alpha»-tetrahydroxy-5«beta»-cholanoic acid, methyl ester-trimethylsilyl-ether derivative
|
|
2 | 9.945 |
| 50-529-9 |
Cholan-24-oic acid, 3,7,12-tris[(trimethylsilyl)oxy]-, methyl ester, (3«alpha»,5«beta»,7«alpha»,12«alpha»)-
|
6818-43-5 |
2 | 9.115 |
| 50-582-0 |
7«alpha»-hydroxy-3-oxo-4-chol-24-oate, O-methyloxime, TMS (1)
|
|
2 | 8.192 |
| 50-591-0 |
7-«alpha»,17-«beta»-Dimethyl-5-«beta»-Androstane-3-«alpha»,17-«alpha»-diol, per-TMS
|
|
2 | 8.105 |
| 50-626-1 |
Silane, diethyl(2,7-dimethyloct-1-en-3-yn-5-yloxy)heptyloxy-
|
|
2 | 6.466 |
| 50-735-0 |
9H-purine-9-acetic acid, 6(1h)-thio-, ethyl ester
|
|
2 | 0.570 |
| 50-804-3 |
13,14-Dihydro-15-keto-PGE2, MO-TMS, isomer # 1
|
|
2 | 7.703 |
|
« Previous Results
Next Results »
|